Years of losses, thin profit margins leave 160 Health feeling down
After two earlier failures, the online healthcare platform’s IPO has been approved by the Hong Kong Stock Exchange Key Takeaways: 160 Health has been approved to list in Hong Kong,…
PomDoc offers up well-conceived but overvalued digital healthcare IPO
The online health services provider aims to raise up to $30 million through a Nasdaq listing, even as its liabilities far outweigh its assets Key Takeaways: PomDoc aims to raise…
Bumper dividend could trigger buyout for Ping An Health
Months after eking out its first profit, the online healthcare platform is planning to drain most of its financial reserves to pay a whopping special dividend Key Takeaways: The firm…
HealthyWay seeks Hong Kong IPO to staunch flow of red ink
The digital healthcare services platform counts Baidu as a major customer, as well as other firms from the pharmaceutical, information technology and insurance sectors Key Takeaways: Digital healthcare services platform…
Third time’s the charm: Fangzhou finally finds winning tonic for Hong Kong IPO
The company has become the latest internet healthcare stock to list, but continues to lose money and remains heavily reliant on drug sales Key Takeaways: Fangzhou has been approved to…
Slowing revenue growth hurts online drug platform YSB
The B2B drug distributor posted higher annual revenues and swung to an adjusted profit, but disappointed investors still sent the firm’s stock down 9% on the day after the earnings…
Ping An Health pins recovery hopes on new leadership
The ailing healthcare platform brought in a whole new management team three years ago to drive a business turnaround but it is changing leaders again Key Takeaways: The Covid pandemic…
Recent Articles
RELATED ARTICLES
-
ShanH seeks IPO recharge after years of losses
- PomDoc offers up well-conceived but overvalued digital healthcare IPO
- Pateo Connect revs up for IPO, belching widening losses and slumping margins
-
Nio’s road to profitability obscured in haze of losses
9866.HK NIO.US
- Anew Health taps investor ‘Qi’ with Nasdaq listing plan
-
From ‘magic tea’ to dietary drugs, can Besunyen reclaim its glory days？
0926.HK
